cilostazol

Generic: cilostazol

Labeler: teva pharmaceuticals usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cilostazol
Generic Name cilostazol
Labeler teva pharmaceuticals usa, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

cilostazol 50 mg/1

Manufacturer
Teva Pharmaceuticals USA, Inc.

Identifiers & Regulatory

Product NDC 0093-2065
Product ID 0093-2065_01457771-0b8c-4f1b-8513-01ad09ac97cc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077027
Listing Expiration 2026-12-31
Marketing Start 2012-04-24

Pharmacologic Class

Established (EPC)
phosphodiesterase 3 inhibitor [epc]
Mechanism of Action
phosphodiesterase 3 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00932065
Hyphenated Format 0093-2065

Supplemental Identifiers

RxCUI
242461 242462
UNII
N7Z035406B
NUI
N0000175598 N0000175086

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cilostazol (source: ndc)
Generic Name cilostazol (source: ndc)
Application Number ANDA077027 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (0093-2065-06)
source: ndc

Packages (1)

0093-2065-06 60 TABLET in 1 BOTTLE (0093-2065-06)

Ingredients (1)

cilostazol (50 mg/1)

Linked Drug Pages (1)

Cilostazol ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "01457771-0b8c-4f1b-8513-01ad09ac97cc", "openfda": {"nui": ["N0000175598", "N0000175086"], "unii": ["N7Z035406B"], "rxcui": ["242461", "242462"], "spl_set_id": ["a6292311-9cb2-49ff-b8bf-12e2dbd196cd"], "pharm_class_epc": ["Phosphodiesterase 3 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 3 Inhibitors [MoA]"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (0093-2065-06)", "package_ndc": "0093-2065-06", "marketing_start_date": "20120424"}], "brand_name": "Cilostazol", "product_id": "0093-2065_01457771-0b8c-4f1b-8513-01ad09ac97cc", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 3 Inhibitor [EPC]", "Phosphodiesterase 3 Inhibitors [MoA]"], "product_ndc": "0093-2065", "generic_name": "Cilostazol", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cilostazol", "active_ingredients": [{"name": "CILOSTAZOL", "strength": "50 mg/1"}], "application_number": "ANDA077027", "marketing_category": "ANDA", "marketing_start_date": "20120424", "listing_expiration_date": "20261231"}